TY - JOUR
T1 - Gli1+ pericyte loss induces capillary rarefaction and proximal tubular injury
AU - Kramann, Rafael
AU - Wongboonsin, Janewit
AU - Chang-Panesso, Monica
AU - Machado, Flavia G.
AU - Humphreys, Benjamin D.
N1 - Funding Information:
This work was supported by the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases grants DK107274, DK103740, and DK103050, and by an Established Investigator Award of the American Heart Association (all to B.D.H); by a Start grant of the Rheinisch-Westfälische Technische Hochschule Aachen University (101/15), a grant of the Deutsche Forschungsgemeinschaft (KR 4073/3-1), a grant of the European Research Council (ERC-StG 677448), and a grant of the State of North Rhine-Westphalia (all to R.K.); and by a Prince Mahidol Award-Youth Program scholarship and fellowship from the Faculty of Medicine at Siriraj Hospital, Mahidol University (to J.W.). We also acknowledge support from the University of Alabama at Birmingham-University of California at San Diego O9Brien Core Center for Acute Kidney Injury Research (NIH grant P30-DK079337).
Publisher Copyright:
© 2017 by the American Society of Nephrology.
PY - 2017/3
Y1 - 2017/3
N2 - Peritubular capillary rarefaction is hypothesized to contribute to the increased risk of future CKD after AKI. Here, we directly tested the role of Gli1+ kidney pericytes in the maintenance of peritubular capillary health, and the consequences of pericyte loss during injury. Using bigenic Gli1-CreERt2; R26tdTomato reporter mice, we observed increased distance between Gli1+ pericytes and endothelial cells after AKI (mean6 SEM: 3.360.1 mm before injury versus 12.560.2 mm after injury; P,0.001). Using a genetic ablationmodel, we asked whether pericyte loss alone is sufficient for capillary destabilization. Ten days after pericyte ablation, we observed endothelial cell damage by electron microscopy. Furthermore, pericyte loss led to significantly reduced capillary number at later time points (mean6SEM capillaries/high-power field: 67.664.7 in control versus 44.164.8 at 56 days; P,0.05) and increasedcross-sectional area (mean6 SEM: 21.960.4 mm2 in control versus 24.160.6 mm2 at 10 days; P,0.01 and 24.66 0.6 μm2 at 56 days; P,0.001). Pericyte ablation also led to hypoxic focal and subclinical tubular injury, reflected by transient expression of Kim1 and vimentin in scattered proximal tubule segments. This analysis provides direct evidence that AKI causes pericyte detachment fromcapillaries, and that pericyte loss is sufficient to trigger transient tubular injury and permanent peritubular capillary rarefaction.
AB - Peritubular capillary rarefaction is hypothesized to contribute to the increased risk of future CKD after AKI. Here, we directly tested the role of Gli1+ kidney pericytes in the maintenance of peritubular capillary health, and the consequences of pericyte loss during injury. Using bigenic Gli1-CreERt2; R26tdTomato reporter mice, we observed increased distance between Gli1+ pericytes and endothelial cells after AKI (mean6 SEM: 3.360.1 mm before injury versus 12.560.2 mm after injury; P,0.001). Using a genetic ablationmodel, we asked whether pericyte loss alone is sufficient for capillary destabilization. Ten days after pericyte ablation, we observed endothelial cell damage by electron microscopy. Furthermore, pericyte loss led to significantly reduced capillary number at later time points (mean6SEM capillaries/high-power field: 67.664.7 in control versus 44.164.8 at 56 days; P,0.05) and increasedcross-sectional area (mean6 SEM: 21.960.4 mm2 in control versus 24.160.6 mm2 at 10 days; P,0.01 and 24.66 0.6 μm2 at 56 days; P,0.001). Pericyte ablation also led to hypoxic focal and subclinical tubular injury, reflected by transient expression of Kim1 and vimentin in scattered proximal tubule segments. This analysis provides direct evidence that AKI causes pericyte detachment fromcapillaries, and that pericyte loss is sufficient to trigger transient tubular injury and permanent peritubular capillary rarefaction.
UR - http://www.scopus.com/inward/record.url?scp=85020690602&partnerID=8YFLogxK
U2 - 10.1681/ASN.2016030297
DO - 10.1681/ASN.2016030297
M3 - Article
C2 - 27624490
AN - SCOPUS:85020690602
SN - 1046-6673
VL - 28
SP - 776
EP - 784
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 3
ER -